Aug 27, 2020
Thyrocare share price rise shows diagnostic sector valuations over-stretching
Thyrocare share price rise shows diagnostic sector valuations over-stretching
[ad_1]
Stocks of diagnostic chains are seeing a sharp rebound even rising over the pre-pandemic levels. Covid-19 cases are increasing, driving the demand for testing but the sharp run-up in the sector leaves little room for upsides.
Agreed, the covid-19 testing may have kept the cash registers ringing in the last quarter. However, some of the government’s testing capacities have increased.…
View On WordPress